Publicaciones en las que colabora con Iván D. Benítez Iglesias (24)

2024

  1. MicroRNA-centered theranostics for pulmoprotection in critical COVID-19

    Molecular Therapy Nucleic Acids, Vol. 35, Núm. 1

  2. MicroRNA-guided drug discovery for mitigating persistent pulmonary complications in critical COVID-19 survivors: A longitudinal pilot study

    British Journal of Pharmacology

2023

  1. A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study

    Respiratory Research, Vol. 24, Núm. 1

  2. Driving pressure and adjunctive therapies in pulmonary sequelae of COVID-19 patients under invasive ventilation

    Intensive Care Medicine

  3. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  4. Long-term Outcomes in Critical COVID-19 Survivors: A 2-Year Longitudinal Cohort

    Archivos de Bronconeumologia, Vol. 59, Núm. 10, pp. 691-697

  5. Study protocol for the epigenetic characterization of angor pectoris according to the affected coronary compartment: Global and comprehensive assessment of the relationship between invasive coronary physiology and microRNAs

    PLoS ONE, Vol. 18, Núm. 5 May

2022

  1. Bronchial Aspirate-Based Profiling Identifies MicroRNA Signatures Associated With COVID-19 and Fatal Disease in Critically Ill Patients

    Frontiers in Medicine, Vol. 8

  2. Endogenous controls and microRNA profile in female patients with obstructive sleep apnea

    Scientific Reports, Vol. 12, Núm. 1

  3. Genome-wide transcriptional profiling of pulmonary functional sequelae in ARDS- secondary to SARS-CoV-2 infection

    Biomedicine and Pharmacotherapy, Vol. 154

  4. Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS

    Emerging Microbes and Infections, Vol. 11, Núm. 1, pp. 1537-1549

  5. Impact of time to intubation on mortality and pulmonary sequelae in critically ill patients with COVID-19: a prospective cohort study

    Critical care (London, England), Vol. 26, Núm. 1, pp. 18

  6. Multiplex protein profiling of bronchial aspirates reveals disease-, mortality- and respiratory sequelae-associated signatures in critically ill patients with ARDS secondary to SARS-CoV-2 infection

    Frontiers in Immunology, Vol. 13

  7. One Year Overview and Follow-Up in a Post-COVID Consultation of Critically Ill Patients

    Frontiers in Medicine, Vol. 9

  8. Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study

    The Lancet Regional Health - Europe, Vol. 18

  9. Sleep and Circadian Health of Critical COVID-19 Survivors 3 Months After Hospital Discharge

    Critical care medicine, Vol. 50, Núm. 6, pp. 945-954

  10. Sleep and circadian health 6 months after critical COVID-19 disease

    Respirology

  11. Three to Six Months Evolution of Pulmonary Function and Radiological Features in Critical COVID-19 Patients: A Prospective Cohort

    Archivos de Bronconeumologia, Vol. 58, pp. 59-62

2021

  1. Clinical management and outcome differences between first and second waves among COVID-19 hospitalized patients: A regional prospective observational cohort

    PLoS ONE, Vol. 16, Núm. 10 October

  2. Peripheral blood microRNAs and the COVID-19 patient: methodological considerations, technical challenges and practice points

    RNA Biology, Vol. 18, Núm. 5, pp. 688-695